The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...
The FDA approved epcoritamab-bysp in combination with lenalidomide and rituximab for patients with relapsed or refractory ...
With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken ...
The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback